The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Constantino Michael T. since 2020.
This trader's CIK number is 1817285.
At the time of last reporting, Constantino Michael T. was the Officer of Humacyte, Inc.. (stock ticker symbol HUMA).
Also see all insider trading activities at Humacyte, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | HUMA | 16,000 | $20,160 | 0 | $0 | 0 | $0 |
| 2024 | HUMA | 7,700 | $39,672 | 0 | $0 | 0 | $0 |
| 2023 | HUMA | 4,750 | $19,855 | 0 | $0 | 0 | $0 |
| 2022 | HUMA | 2,000 | $9,660 | 0 | $0 | 0 | $0 |
| 2021 | HUMA | 2,500 | $27,027 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NMTR | 16,000 | $7,616 | 0 | $0 | 0 | $0 |
| 2021 | NMTR | 18,000 | $20,520 | 0 | $0 | 0 | $0 |
| 2020 | NMTR | 34,108 | $25,581 | 0 | $0 | 0 | $0 |
2. 9 Meters Biopharma, Inc. (NMTR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-07 | HUMA | Buy | 16,000 | 1.26 | 20,160 |
| 2024-12-04 | HUMA | Buy | 4,600 | 4.39 | 20,180 |
| 2024-08-15 | HUMA | Buy | 3,100 | 6.29 | 19,492 |
| 2023-05-18 | HUMA | Buy | 4,750 | 4.18 | 19,855 |
| 2022-05-23 | HUMA | Buy | 2,000 | 4.83 | 9,660 |
| 2021-11-22 | HUMA | Buy | 2,500 | 10.81 | 27,027 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-23 | NMTR | Buy | 16,000 | .48 | 7,616 |
| 2021-08-24 | NMTR | Buy | 18,000 | 1.14 | 20,520 |
| 2020-08-20 | NMTR | Buy | 34,108 | .75 | 25,581 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Constantino Michael T. (Officer of Humacyte, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.